Market Tracker

08/21 6:05pm ET

Incyte Corp (NASDAQ:INCY)

During the Trading Day
50.19 -1.47 / -2.85%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
50.28 +0.0944 / +0.19%
 
Volume: 31.2K

Today’s Trading

Previous close51.66
Today’s open51.95
Day’s range49.72 - 52.14
Volume754,991
Average volume (3 months)1,144,155
Market cap$8.7B
Dividend yield--
Data as of 4:00pm ET, 08/21/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+38.72%
Earnings growth (next 5 years)+83.94%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc-1.86-1.54%
MNKMallinckrodt Plc-1.25-1.73%
HSPHospira Inc-0.17-0.31%
RDYDr.Reddy's Laborator...-0.78-1.64%
Data as of 4:03pm ET, 08/21/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David C. Hastings
Corporate headquarters
Wilmington, Delaware

Forecasts